Ion Beam Applications (IOBCF) Stock Price, News & Analysis

Company Overview

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications. Its Radiopharma division supplies cyclotron systems and automated quality control modules used in the production of PET isotopes, enabling advanced diagnostic imaging across hospitals and research centers. The company’s Industrial segment offers e-beam and X-ray irradiation solutions for sterilization, food safety, polymer crosslinking, and wood modification, serving clients in healthcare, food processing, and manufacturing.

Over more than three decades, IBA has installed proton therapy centers and industrial radiation systems in more than 30 countries, with projects spanning Europe, North America, Asia, the Middle East, and Latin America. The company collaborates with leading medical institutions, cancer research centers, and regulatory bodies to advance clinical protocols and improve access to cutting-edge treatments. Strategic partnerships and service agreements help IBA maintain a global footprint and ensure high uptime and performance for its installed base.

Since April 2021, IBA has been led by Chief Executive Officer Javier Garcia Sanz, who has emphasized innovation in compact system design and digital services to support clinical workflows and expand market reach. Looking ahead, the company continues to invest in R&D aimed at reducing treatment costs, improving patient throughput, and exploring novel applications of particle beam technology in oncology and beyond.

Key Stats

• Today's Range: $13.00 to $13.00
• 50-Day Range: $12.53 to $13.95
• 52-Week Range: $10.15 to $15.35
• Volume: 1,500 shs
• Average Volume: 674 shs
• Market Capitalization: N/A
• P/E Ratio: 153.36
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Ion Beam Applications Stock Analysis - MarketRank™

Ion Beam Applications scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ion Beam Applications.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ion Beam Applications is 153.36, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 82.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ion Beam Applications is 153.36, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.67.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Ion Beam Applications has a short interest ratio ("days to cover") of 5.

Change versus previous month

Short interest in Ion Beam Applications has recently decreased by 83.87%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ion Beam Applications does not currently pay a dividend.

Dividend Growth

Ion Beam Applications does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Ion Beam Applications has a short interest ratio ("days to cover") of 5.

Change versus previous month

Short interest in Ion Beam Applications has recently decreased by 83.87%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: N/A

News Sentiment

Ion Beam Applications has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Ion Beam Applications this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ion Beam Applications insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 14.86% of the stock of Ion Beam Applications is held by institutions.

IOBCF Stock Analysis - Frequently Asked Questions

How have IOBCF shares performed this year?

Ion Beam Applications' stock was trading at $13.85 on January 1st, 2025. Since then, IOBCF stock has decreased by 6.1% and is now trading at $13.00.

How do I buy shares of Ion Beam Applications?

Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:IOBCF
• CIK: N/A
• Web: www.iba-worldwide.com
• Phone: (321) 047-5811
• Fax: N/A
• Employees: 2,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 163.98
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A